C
CHARM Therapeutics is discovering and developing small molecule medicines against difficult-to-drug targets with our proprietary 3D deep learning-enabled platform, DragonFold. Powered by the first high throughput protein-ligand co-folding algorithm and a world-class team of scientists and engineers, CHARM seeks to deliver innovative approaches to create life-changing therapies for patients.
Investor insights
Funding rounds participated in
$20M sweet spot round size
Investor type
Privately Held
Basic info
Industry
Research Services
Sectors
Research Services
Date founded
2021
Funding rounds raised
Total raised
$20M
from 1 investors over 1 rounds
C
CHARM Therapeutics raised $20M on May 14, 2023
Investors: NVentures